Ropinirole Hydrochloride
20 NDCs across 3 manufacturers|20 Generic,0 Brand
Ropinirole Hydrochloride is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Sep 19, 1997, and the first generic was approved May 5, 2008. FDA's Orange Book lists 91 AB-rated (therapeutically equivalent) products for this ingredient.
Ropinirole Hydrochloride is available as 20 NDCs from 3 manufacturers (20 generic, 0 brand), with NADAC prices from $0.04 to $0.08 per EA — a 93% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
20
20G / 0B
Manufacturers
3
competing in market
Price Spread
$0.04 – $0.08
per EA
7d Activity
avg -1.1% WoW · of 20 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
3 manufacturers producing ROPINIROLE HYDROCHLORIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ROPINIROLE HCL 5 MG TABLET | $0.0832 per EA | +2.61% |
ROPINIROLE HCL 5 MG TABLET | $0.0832 per EA | +2.61% |
ROPINIROLE HCL 4 MG TABLET | $0.0818 per EA | -0.90% |
ROPINIROLE HCL 4 MG TABLET | $0.0818 per EA | -0.90% |
ROPINIROLE HCL 3 MG TABLET | $0.0806 per EA | -4.05% |
ROPINIROLE HCL 3 MG TABLET | $0.0806 per EA | -4.05% |
ROPINIROLE HCL 2 MG TABLET | $0.0664 per EA | -1.10% |
ROPINIROLE HCL 2 MG TABLET | $0.0664 per EA | -1.10% |
ROPINIROLE HCL 2 MG TABLET | $0.0664 per EA | -1.10% |
ROPINIROLE HCL 1 MG TABLET | $0.0488 per EA | -4.25% |
ROPINIROLE HCL 1 MG TABLET | $0.0488 per EA | -4.25% |
ROPINIROLE HCL 1 MG TABLET | $0.0488 per EA | -4.25% |
ROPINIROLE HCL 1 MG TABLET | $0.0488 per EA | -4.25% |
ROPINIROLE HCL 0.25 MG TABLET | $0.0456 per EA | +0.62% |
ROPINIROLE HCL 0.25 MG TABLET | $0.0456 per EA | +0.62% |
ROPINIROLE HCL 0.25 MG TABLET | $0.0456 per EA | +0.62% |
ROPINIROLE HCL 0.25 MG TABLET | $0.0456 per EA | +0.62% |
ROPINIROLE HCL 0.5 MG TABLET | $0.0430 per EA | -0.07% |
ROPINIROLE HCL 0.5 MG TABLET | $0.0430 per EA | -0.07% |
ROPINIROLE HCL 0.5 MG TABLET | $0.0430 per EA | -0.07% |
Frequently Asked Questions
What is Ropinirole Hydrochloride used to treat?
Ropinirole Hydrochloride is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
When did Ropinirole Hydrochloride become available as a generic?
FDA approved the first generic Ropinirole Hydrochloride (ANDA) on May 5, 2008. The Orange Book currently lists 91 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How many Ropinirole Hydrochloride products are on the market?
The Ropinirole Hydrochloride drug market contains 20 NDCs from 3 manufacturers — 20 generic and 0 brand products.
What is the price range for Ropinirole Hydrochloride?
NADAC reference prices for Ropinirole Hydrochloride range from $0.0430 to $0.0832 per EA — a 93% difference between cheapest and most expensive.
Which manufacturers make Ropinirole Hydrochloride?
3 manufacturers list Ropinirole Hydrochloride in NADAC. Ranked by number of NDCs, the largest are Solco Healthcare US LLC (14), AvPAK (4), American Health Packaging (2).
How has the price of Ropinirole Hydrochloride changed recently?
Over the past 7 days, 6 Ropinirole Hydrochloride NDCs rose and 14 fell, with a market-wide average change of -1.1%.